Inspire Medical Systems (NYSE:INSP) issued its quarterly earnings results on Tuesday. The company reported ($0.60) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.66) by $0.06, MarketWatch Earnings reports. Inspire Medical Systems had a negative net margin of 61.07% and a negative return on equity of 32.23%. The company had revenue of $40.30 million for the quarter, compared to the consensus estimate of $49.10 million. During the same quarter in the prior year, the company earned ($0.67) EPS. Inspire Medical Systems’s quarterly revenue was up 89.2% on a year-over-year basis. Inspire Medical Systems updated its FY 2021 guidance to – EPS.
Shares of Inspire Medical Systems stock opened at $226.53 on Wednesday. The company has a current ratio of 14.67, a quick ratio of 14.18 and a debt-to-equity ratio of 0.11. Inspire Medical Systems has a twelve month low of $65.71 and a twelve month high of $252.25. The firm has a market capitalization of $6.15 billion, a PE ratio of -97.64 and a beta of 1.71. The firm’s 50-day moving average price is $216.84 and its 200 day moving average price is $198.60.
A number of analysts have recently weighed in on INSP shares. SVB Leerink increased their price objective on shares of Inspire Medical Systems from $225.00 to $275.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 2nd. Zacks Investment Research cut Inspire Medical Systems from a “hold” rating to a “sell” rating in a report on Wednesday, April 28th. Lake Street Capital lifted their price target on Inspire Medical Systems from $215.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, February 24th. Piper Sandler upped their price objective on Inspire Medical Systems from $210.00 to $252.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 2nd. Finally, Robert W. Baird reaffirmed a “buy” rating on shares of Inspire Medical Systems in a report on Sunday, April 25th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $171.50.
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
See Also: How to invest using market indexes
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.